Sanofi plans to shake up 'stagnant' industry
Sanofi-Aventis hopes it can buck a pharma industry trend of declining numbers of new drugs with potentially 31 new drug submissions over the next 3 years.
Archives for September 17, 2007
FDA gives guidance on biologics-producing spore-forming microbes
The US Food and Drug Administration (FDA) has released new recommendations for manufacturers of biologics using spore-forming microorganisms.
Nanogen to shutter microarray business?
US-based diagnostics manufacturer Nanogen is considering selling off or closing down its microarray business in a bid to achieve profitability.
ZaCh Systems acquires fine chemicals unit
ZaCh Systems has acquired PPG Industries' fine chemicals business for approximately $65m (€46.9m), which includes a pharmaceutical fine chemicals facility in Texas.
Massive counterfeit drug ring cracked
The biggest counterfeit drugs conspiracy ever to be encountered in the UK was crushed this week, as gang members were found guilty of conspiracy by a UK court following a lengthy investigation by the authorities.
Microbia, Forest pen IBS collaboration
Microbia and Forest Laboratories have penned a multi-million dollar deal over the former's first-in-class drug to treat irritable bowel syndrome (IBS).
BMS to outsource some pharmacovigilance operations to India
Bristol-Myers Squibb (BMS) is moving part of its drug safety monitoring operations to India in an unprecedented move for the pharma industry.